Search: onr:"swepub:oai:gup.ub.gu.se/277271" >
Treatment of hepati...
Treatment of hepatitis C virus infection for adults and children: updated Swedish consensus guidelines 2017
-
- Lagging, Martin, 1965 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine,Department of Infectious Diseases, Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
-
- Wejstål, Rune, 1952 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine,Department of Infectious Diseases, Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
-
- Duberg, Ann-Sofi, Docent, 1957- (author)
- Örebro universitet,Institutionen för medicinska vetenskaper,Department of Infectious Diseases
-
show more...
-
- Aleman, S. (author)
- Karolinska Institutet
-
- Weiland, O. (author)
- Karolinska Institutet
-
- Westin, Johan, 1965 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine,Department of Infectious Diseases, Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Swedish Reference Group for Antiviral Therapy (RAV), Stockholm, Sweden
-
show less...
-
(creator_code:org_t)
- 2018-03-01
- 2018
- English.
-
In: Infectious Diseases. - : Informa UK Limited. - 2374-4235 .- 2374-4243. ; 50:8, s. 569-583
- Related links:
-
https://www.tandfonl...
-
show more...
-
https://doi.org/10.1...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Aim: Following the approval of two new therapeutic combinations within the European Union in 2017, the former Swedish recommendations for the treatment of hepatitis C virus (HCV) infection from 2016 were deemed in need of updating. Materials and methods: An expert meeting to this end was held in Stockholm, Sweden in October 2017. Results and conclusions: An interferon-free combination of direct-acting antiviral agents is now recommended for all patients with chronic HCV infection, regardless of liver fibrosis stage, in order to limit morbidity and spread of the disease. An extended discussion of treatment for people who inject drugs in order to diminish transmission is included.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
Keyword
- Hepatitis C virus
- HCV
- Guidelines
- Direct-acting antiviral agents
- Ribavirin
- Genotype
- People who inject drugs
- PWIDs
- Children
- Chronic
- kidney disease
- HIV
- Elimination
- Eradication
- Resistance associated
- variants (RAVs)
- Resistance associated substitutions (RASs)
- genotype 1 infection
- daclatasvir plus sofosbuvir
- treatment-experienced
- patients
- treatment-naive patients
- severe renal impairment
- fixed-dose
- combination
- open-label
- hcv infection
- hepatocellular-carcinoma
- phase-3 trial
- Infectious Diseases
- Hepatitis C virus
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database